Wellington Management Group
TEVA icon

Wellington Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Wellington Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,629
Closed -$1.31M – 2316
2017
Q4 		$1.31M Sell
3,629
-396
-10% -$5.96K ﹤0.01% 1837
2017
Q3 		$865K Buy
4,025
+3,025
+303% +$68.1K ﹤0.01% 1923
2017
Q2 		$620K Buy
+1,000
New +$31K ﹤0.01% 1990

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Wellington Management Group's TEVA Position: Q2 2026 in Review

Wellington Management Group increased its Teva Pharmaceuticals (TEVA) stake by 5.8% in Q2 2026, buying an estimated $14M and bringing the position to 7,671,157 shares worth $260M. The position accounts for 0.04% of the portfolio, ranked #333.

Wellington Management Group first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.4B in Q2 2013. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Wellington Management Group held 7,671,157 shares of Teva Pharmaceuticals worth $260M as of Q2 2026.
  • Wellington Management Group bought 419,329 Teva Pharmaceuticals shares in Q2 2026, an estimated $14M.
  • Teva Pharmaceuticals made up 0.04% of Wellington Management Group's portfolio in Q2 2026, its #333 holding.
  • Wellington Management Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Wellington Management Group's Teva Pharmaceuticals position peaked at $2.4B in Q2 2013.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.